Article Versions Notes

Sarkar T, Moinuddin SM, Isbatan A, Chen J, Mann D, Ahsan F. Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil and/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension. Pharmaceuticals. 2023; 16(12):1656. https://doi.org/10.3390/ph16121656

Sarkar, Tanoy, Sakib M. Moinuddin, Ayman Isbatan, Jiwang Chen, David Mann, and Fakhrul Ahsan. 2023. "Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil and/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension" Pharmaceuticals 16, no. 12: 1656. https://doi.org/10.3390/ph16121656

Sarkar, T., Moinuddin, S. M., Isbatan, A., Chen, J., Mann, D., & Ahsan, F. (2023). Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil and/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension. Pharmaceuticals, 16(12), 1656. https://doi.org/10.3390/ph16121656